Presentation

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Presenter: Roxana Mehran

September 26, 2019

REGISTER for free or LOG IN to view this content

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Coronary

Presentation

TCT 2019

Up Next

Presentation

De-Escalation: When and How? — The Role of Platelet Function and Genetic Testing

Presenter: Francesco Franchi

September 26, 2019

More slides +

Presentation

Early Feasibility of the Metavention Integrated Radio Frequency Nerve Ablation System to Improve Hyperglycemia and Fatty Liver in Type II Diabetic Subjects (Metavention)

Presenter: Felix Mahfoud

September 26, 2019

Presentation

Rapid-Fire Review of Transcatheter Mitral Valve Devices

Presenter: Konstantinos Koulogiannis

September 26, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.